This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Reply to Letter to the Editor "Sexual Dysfunction and Fluvoxamine Therapy"

Anne N. Nafziger, Joseph S. Bertino, Jr., Angelica I. Goss-Bley, and Angela D. M. Kashuba

Published: February 2, 2001

Article Abstract

Letter to the Editor

Sir: We appreciate the insightful comments of Drs. Waldinger and Olivier. While we agree that objective measurements of sexual function are potentially more accurate and useful than self-report questionnaires, it is difficult (and for most clinicians, impossible) to implement objective measurements in clinical practice. We agree that it is unfortunate that accurate instrumental tools (including standardized questionnaires) are seldom used in psychiatric sexual pharmacologic studies. In fact, they are seldom used in any pharmacologic studies.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 62

Quick Links: Depression (MDD) , Sexual Dysfunction


Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...